160 related articles for article (PubMed ID: 15169784)
41. MTA1 and MTA3 Regulate HIF1a Expression in Hypoxia-Treated Human Trophoblast Cell Line HTR8/Svneo.
Wang K; Chen Y; Ferguson SD; Leach RE
Med J Obstet Gynecol; 2013 Dec; 1(3):. PubMed ID: 25705708
[TBL] [Abstract][Full Text] [Related]
42. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
43. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
[TBL] [Abstract][Full Text] [Related]
44. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
45. Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s.
Singh RR; Kaluarachchi K; Chen M; Rayala SK; Balasenthil S; Ma J; Kumar R
J Biol Chem; 2006 Sep; 281(35):25612-21. PubMed ID: 16807247
[TBL] [Abstract][Full Text] [Related]
46. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Martini PG; Katzenellenbogen BS
Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
[TBL] [Abstract][Full Text] [Related]
47. MTA1 regulation of ERβ pathway in salivary gland carcinoma cells.
Ohshiro K; Kumar R
Biochem Biophys Res Commun; 2015 Sep; 464(4):1016-1021. PubMed ID: 26168722
[TBL] [Abstract][Full Text] [Related]
48. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene.
Molli PR; Singh RR; Lee SW; Kumar R
Oncogene; 2008 Mar; 27(14):1971-80. PubMed ID: 17922032
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional regulation of mouse mu opioid receptor gene by PU.1.
Hwang CK; Kim CS; Choi HS; McKercher SR; Loh HH
J Biol Chem; 2004 May; 279(19):19764-74. PubMed ID: 14998994
[TBL] [Abstract][Full Text] [Related]
50. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation.
Yan C; Wang H; Toh Y; Boyd DD
J Biol Chem; 2003 Jan; 278(4):2309-16. PubMed ID: 12431981
[TBL] [Abstract][Full Text] [Related]
51. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.
An J; Ribeiro RC; Webb P; Gustafsson JA; Kushner PJ; Baxter JD; Leitman DC
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15161-6. PubMed ID: 10611355
[TBL] [Abstract][Full Text] [Related]
52. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform.
Waters KM; Rickard DJ; Riggs BL; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Moore J; Spelsberg TC
J Cell Biochem; 2001 Aug 21-Sep 5; 83(3):448-62. PubMed ID: 11596113
[TBL] [Abstract][Full Text] [Related]
53. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO.
Dannenmann C; Shabani N; Friese K; Jeschke U; Mylonas I; Brüning A
Cancer Biol Ther; 2008 Sep; 7(9):1460-7. PubMed ID: 18719363
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites.
Petz LN; Ziegler YS; Schultz JR; Kim H; Kemper JK; Nardulli AM
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):113-22. PubMed ID: 15084343
[TBL] [Abstract][Full Text] [Related]
55. Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family.
Schuur ER; Loktev AV; Sharma M; Sun Z; Roth RA; Weigel RJ
J Biol Chem; 2001 Sep; 276(36):33554-60. PubMed ID: 11435445
[TBL] [Abstract][Full Text] [Related]
56. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.
Shang Y; Hu X; DiRenzo J; Lazar MA; Brown M
Cell; 2000 Dec; 103(6):843-52. PubMed ID: 11136970
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells.
You Y; Cui Y; Li Y; Zhang M; Wang X; Ji J; Zhang X; Zhou M; Zhang Z; Ye SD; Wang X
Biochem Biophys Res Commun; 2021 May; 552():142-149. PubMed ID: 33744762
[TBL] [Abstract][Full Text] [Related]
58. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
59. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
Chen H; Tu SW; Hsieh JT
J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
